BRPI0401467A - Corpos porosos com revestimento antibiótico, processo para a preparação, bem como aplicação - Google Patents
Corpos porosos com revestimento antibiótico, processo para a preparação, bem como aplicaçãoInfo
- Publication number
- BRPI0401467A BRPI0401467A BR0401467-7A BRPI0401467A BRPI0401467A BR PI0401467 A BRPI0401467 A BR PI0401467A BR PI0401467 A BRPI0401467 A BR PI0401467A BR PI0401467 A BRPI0401467 A BR PI0401467A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- antibiotic
- well
- application
- porous bodies
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title abstract 6
- 238000002360 preparation method Methods 0.000 title abstract 2
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 abstract 3
- 229960004675 fusidic acid Drugs 0.000 abstract 3
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 abstract 3
- 239000011148 porous material Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000007864 aqueous solution Substances 0.000 abstract 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 abstract 1
- 229930182566 Gentamicin Natural products 0.000 abstract 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004100 Oxytetracycline Substances 0.000 abstract 1
- URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 108010059993 Vancomycin Proteins 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 abstract 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 abstract 1
- 229960003405 ciprofloxacin Drugs 0.000 abstract 1
- 229960002227 clindamycin Drugs 0.000 abstract 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 abstract 1
- 229960002518 gentamicin Drugs 0.000 abstract 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 abstract 1
- 229960005287 lincomycin Drugs 0.000 abstract 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 abstract 1
- 229960003702 moxifloxacin Drugs 0.000 abstract 1
- ZBGPYVZLYBDXKO-HILBYHGXSA-N netilmycin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@]([C@H](NC)[C@@H](O)CO1)(C)O)NCC)[C@H]1OC(CN)=CC[C@H]1N ZBGPYVZLYBDXKO-HILBYHGXSA-N 0.000 abstract 1
- 229960000625 oxytetracycline Drugs 0.000 abstract 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 abstract 1
- 235000019366 oxytetracycline Nutrition 0.000 abstract 1
- HMEYVGGHISAPJR-IAHYZSEUSA-N rolitetracycline Chemical compound O=C([C@@]1(O)C(O)=C2[C@@H]([C@](C3=CC=CC(O)=C3C2=O)(C)O)C[C@H]1[C@@H](C=1O)N(C)C)C=1C(=O)NCN1CCCC1 HMEYVGGHISAPJR-IAHYZSEUSA-N 0.000 abstract 1
- 229960005009 rolitetracycline Drugs 0.000 abstract 1
- URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 abstract 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 abstract 1
- 229960000268 spectinomycin Drugs 0.000 abstract 1
- 229960005322 streptomycin Drugs 0.000 abstract 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 229960000707 tobramycin Drugs 0.000 abstract 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 abstract 1
- 229960003165 vancomycin Drugs 0.000 abstract 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 abstract 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"CORPOS POROSOS COM REVESTIMENTO ANTIBIóTICO, PROCESSO PARA A PREPARAçãO, BEM COMO APLICAçãO". A presente invenção refere-se a um corpo poroso com revestimento antibiótico, a preparação e aplicação. No sistema de poros de corpos porosos não-metálicos e de corpos porosos metálicos é introduzido um revestimento de pelo menos um sal de antibióticos pouco solúvel em água ou no meio aquoso do grupo da gentamicina do ácido fusidínico, da sisomicina do ácido fusidínico, da estreptomicina do ácido fusidínico, da tobramicina do ácido fusidínico, da espectinomicina do ácido fusidínico, da vancomicina do ácido fusidínico, da ciprofloxacina do ácido fusidínico, da moxifloxacina do ácido fusidínico, da clindamicina do ácido fusidínico, da lincomicina do ácido fusidínico, da tetraciclina do ácido fusidínico, da clortetraciclina do ácido fusidínico, da oxitetraciclina do ácido fusidínico e da rolitetraciclina do ácido fusidínico. Os corpos porosos, revestidos antibioticamente são empregados como implantes.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10318991A DE10318991A1 (de) | 2003-04-25 | 2003-04-25 | Poröser Körper mit antibiotischer Beschichtung, Verfahren zur Herstellung sowie Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0401467A true BRPI0401467A (pt) | 2005-01-18 |
Family
ID=32946448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0401467-7A BRPI0401467A (pt) | 2003-04-25 | 2004-04-20 | Corpos porosos com revestimento antibiótico, processo para a preparação, bem como aplicação |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20050031664A1 (pt) |
| EP (1) | EP1470829B1 (pt) |
| JP (1) | JP2004321804A (pt) |
| CN (1) | CN1569257A (pt) |
| AT (1) | ATE378077T1 (pt) |
| AU (1) | AU2004200955B2 (pt) |
| BR (1) | BRPI0401467A (pt) |
| CA (1) | CA2459619C (pt) |
| CY (1) | CY1108043T1 (pt) |
| DE (2) | DE10318991A1 (pt) |
| DK (1) | DK1470829T3 (pt) |
| ES (1) | ES2294388T3 (pt) |
| PL (1) | PL1470829T3 (pt) |
| PT (1) | PT1470829E (pt) |
| SI (1) | SI1470829T1 (pt) |
| ZA (1) | ZA200403113B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040224981A1 (en) * | 2003-05-01 | 2004-11-11 | Nebojsa Janjic | Antibacterial methods and compositions |
| DE102006016598A1 (de) * | 2006-04-06 | 2007-11-15 | Heraeus Kulzer Gmbh | Beschichtete Vaskulärimplantate |
| DE102007039871A1 (de) * | 2007-08-21 | 2009-02-26 | Friedrich-Baur-Gmbh | Weichgewebe-Implantat mit antibakterieller Wirkung |
| DE102010020940B4 (de) * | 2010-05-19 | 2014-09-25 | Heraeus Medical Gmbh | Antibiotische Beschichtung |
| DE102010055561B4 (de) | 2010-12-23 | 2015-12-31 | Heraeus Medical Gmbh | Beschichtungsverfahren und Beschichtungsvorrichtung |
| DE102010055560B4 (de) | 2010-12-23 | 2017-02-23 | Heraeus Medical Gmbh | Beschichtungsvorrichtung |
| DE102010055559B4 (de) | 2010-12-23 | 2015-10-29 | Heraeus Medical Gmbh | Beschichtungsverfahren und Beschichtungsvorrichtung |
| DE102010055562B4 (de) | 2010-12-23 | 2015-07-09 | Heraeus Medical Gmbh | Beschichtungsvorrichtung und Beschichtungsverfahren |
| DE102011117526B4 (de) | 2011-11-03 | 2015-07-30 | Heraeus Medical Gmbh | Beschichtungsverfahren und Beschichtungsvorrichtung für medizinische Implantate |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3091572A (en) * | 1962-07-16 | 1963-05-28 | Schering Corp | Gentamycin and method of production |
| FR1468638A (fr) * | 1963-10-22 | 1967-02-10 | Roussel Uclaf | Sels de l'acide fusidique et procédé de préparation |
| DE2442021A1 (de) * | 1974-09-03 | 1976-03-18 | Bayer Ag | Verfahren zur herstellung poroeser koerper auf der basis von gips, insbesondere anhydrit |
| US4291031A (en) * | 1979-02-19 | 1981-09-22 | Fujisawa Pharmaceutical Co., Ltd. | 3-Phosphonocephalosporanic acid derivatives, and pharmaceutical composition comprising the same |
| GB2093348B (en) * | 1981-02-23 | 1984-09-12 | Leo Pharm Prod Ltd | Pharmaceutical composition for implantation |
| DE3206725A1 (de) * | 1981-05-13 | 1982-12-02 | Merck Patent Gmbh, 6100 Darmstadt | Schwer loesliche salze von aminoglykosidantibiotika |
| DE4314871A1 (de) * | 1993-05-05 | 1994-11-10 | Merck Patent Gmbh | Lösungsmittel für ein schwerlösliches Gentamicin-Salz |
| DE19856668A1 (de) * | 1998-12-09 | 2000-06-15 | Aesculap Ag & Co Kg | Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung |
| DE10114244A1 (de) * | 2001-03-22 | 2002-10-02 | Heraeus Kulzer Gmbh & Co Kg | Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung |
| DE10114245A1 (de) * | 2001-03-22 | 2002-10-02 | Heraeus Kulzer Gmbh & Co Kg | Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung |
| DE10114364A1 (de) * | 2001-03-22 | 2002-10-02 | Heraeus Kulzer Gmbh & Co Kg | Verfahren zur Herstellung von antibiotischen Kompositen |
| DE10262176B4 (de) * | 2002-06-21 | 2007-10-04 | Heraeus Kulzer Gmbh | Verfahren zur Herstellung von antibiotisch beschichteten porösen Körpern sowie Verwendung |
-
2003
- 2003-04-25 DE DE10318991A patent/DE10318991A1/de not_active Withdrawn
-
2004
- 2004-02-27 CA CA002459619A patent/CA2459619C/en not_active Expired - Fee Related
- 2004-03-08 AU AU2004200955A patent/AU2004200955B2/en not_active Ceased
- 2004-04-01 SI SI200430568T patent/SI1470829T1/sl unknown
- 2004-04-01 PL PL04007897T patent/PL1470829T3/pl unknown
- 2004-04-01 AT AT04007897T patent/ATE378077T1/de active
- 2004-04-01 PT PT04007897T patent/PT1470829E/pt unknown
- 2004-04-01 DK DK04007897T patent/DK1470829T3/da active
- 2004-04-01 DE DE502004005462T patent/DE502004005462D1/de not_active Expired - Lifetime
- 2004-04-01 EP EP04007897A patent/EP1470829B1/de not_active Expired - Lifetime
- 2004-04-01 ES ES04007897T patent/ES2294388T3/es not_active Expired - Lifetime
- 2004-04-20 BR BR0401467-7A patent/BRPI0401467A/pt not_active IP Right Cessation
- 2004-04-23 US US10/831,680 patent/US20050031664A1/en not_active Abandoned
- 2004-04-23 ZA ZA200403113A patent/ZA200403113B/xx unknown
- 2004-04-23 JP JP2004128288A patent/JP2004321804A/ja active Pending
- 2004-04-26 CN CNA2004100384243A patent/CN1569257A/zh active Pending
-
2008
- 2008-01-18 CY CY20081100073T patent/CY1108043T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1470829B1 (de) | 2007-11-14 |
| AU2004200955A1 (en) | 2004-11-11 |
| US20050031664A1 (en) | 2005-02-10 |
| EP1470829A1 (de) | 2004-10-27 |
| ZA200403113B (en) | 2004-11-05 |
| CA2459619C (en) | 2008-08-12 |
| ATE378077T1 (de) | 2007-11-15 |
| DE10318991A1 (de) | 2004-11-18 |
| ES2294388T3 (es) | 2008-04-01 |
| PL1470829T3 (pl) | 2008-06-30 |
| JP2004321804A (ja) | 2004-11-18 |
| CY1108043T1 (el) | 2013-09-04 |
| SI1470829T1 (sl) | 2008-04-30 |
| AU2004200955B2 (en) | 2007-05-24 |
| CA2459619A1 (en) | 2004-10-25 |
| DK1470829T3 (da) | 2008-01-21 |
| CN1569257A (zh) | 2005-01-26 |
| PT1470829E (pt) | 2007-12-26 |
| DE502004005462D1 (de) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108043T1 (el) | Πορωδη σωματα με αντιβιοτικη επικαλυψη, μεθοδος παραγωγης και χρηση | |
| ZA200304798B (en) | Antibiotic coating of porous bodies and method for manufacture thereof and use thereof. | |
| ATE548543T1 (de) | Walzenheber, verfahren zur herstellung eines walzenhebers und flüssigkeitspumpe | |
| DK1784232T3 (da) | Biologisk aktive klæbeartikler og fremgangsmåder til fremstilling | |
| ATE504236T1 (de) | Wassergel für intravenösen amperometrischen biosensor | |
| BRPI0606574A2 (pt) | métodos de ativação de um revestimento orgânico e de preparação de um tratamento de ativação, substrato revestido e tratamento de ativação para um revestimento orgânico | |
| ATE389043T1 (de) | Verfahren zur beschichtung eines substrates mit calciumphosphat | |
| EP1760171A4 (en) | PRE-TREATMENT AGENT FOR ELECTRODE METAL SEPARATION, METHOD FOR ELECTRICALLY METAL SEPARATION USED THEREOF, AND PRODUCT OF ELECTRICITY METAL SEPARATION | |
| DE602004026323D1 (de) | Verbesserung der uberlebensfähigkeit von kryokonserviertem biologischem material nach dem auftauen durch provokation mit hydrostatischem druck | |
| TW200730248A (en) | Palladium complex and catalyst-imparting treatment solution using the same | |
| BR0309430A (pt) | Composição de revestimento, método para a preparação de uma composição de revestimento, substrato, método para a preparação de um substrato, artigo com múltiplas camadas e método para a produção de um artigo com múltiplas camadas | |
| DE502004003920D1 (de) | Verfahren zur Herstellung von wasserdispergierbaren Celluloseether mit vermindertem Glyoxalgehalt | |
| WO2007053429A3 (en) | Method for coating fibers and yarns and the coated products formed therefrom | |
| TW200724234A (en) | Photocatalystic composite material, method for producing the same and application thereof | |
| WO2010009904A3 (de) | Verfahren zur erzeugung einer bioaktiven oberfläche auf dem ballon eines ballonkatheters | |
| MXPA02008326A (es) | Procedimiento para el revestimiento antibiotico de cuerpos con microhuecos interconectados, cuerpos revestidos de eata manera asi como su uso. | |
| ATE482259T1 (de) | Verfahren zum aufbringen einer haftvermittler- zusammensetzung auf ein substrat | |
| HN2005000114A (es) | Procedimiento para purificar mesotriona. | |
| WO2010140146A3 (en) | Sealants, manufacturing thereof, and applications thereof | |
| BRPI0413208B1 (pt) | composição e processo para melhorar a adesão de um revestimento orgânico secante a uma superfície de metal, bem como superfície de metal revestida orgânica secante | |
| EP1953554A3 (en) | A method for production of physiologically active substance-immobilized substrate | |
| WO2007118329A8 (en) | Methods and agents for treating tuberculosis | |
| RU2006106211A (ru) | Способ формирования белковых пленок на твердых подложках | |
| ATE518940T1 (de) | Flüssiges trennmittel | |
| RU2007100802A (ru) | Способ получения металлических нанокластеров в свободном состоянии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014. |